Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

164.71
Delayed Data
As of Mar 28
 -0.20 / -0.12%
Today’s Change
133.64
Today|||52-Week Range
184.21
+12.65%
Year-to-Date
Pfizer's Arthritis Drug Xeljanz Gets Marketing Nod in Europe
Mar 28 / Zacks.com - Paid Partner Content
6 Best Stocks for Value Investors This Week
Mar 26 / GuruFocus News - Paid Partner Content
The 'Fearless Girl' Statue Isn't a Symbol, It Is an Advertisement
Mar 27 / Zacks.com - Paid Partner Content
Amgen's (AMGN) Humira Biosimilar Receives Approval in EU
Mar 24 / Zacks.com - Paid Partner Content
Amgen's Humira Biosimilar Approved in Europe
Mar 27 / GuruFocus News - Paid Partner Content
Pfizer's Immunotherapy for Skin Cancer Gets FDA Approval
Mar 24 / Zacks.com - Paid Partner Content
J&J (JNJ) Anaemia Drug Marketing Label Expanded in Europe
Mar 27 / Zacks.com - Paid Partner Content
Stock Market News for March 24, 2017
Mar 24 / Zacks.com - Paid Partner Content
Merck's Ketruda Gets Positive CHMP Opinion for Lymphoma
Mar 27 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Amgen, Walgreens Boots Allianc...
Mar 24 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close164.91
Today’s open164.11
Day’s range163.73 - 166.26
Volume6,526,446
Average volume (3 months)3,878,059
Market cap$121.3B
Dividend yield2.79%
Data as of 03/28/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+6.28%
Earnings growth (next 5 years)+6.55%
Revenue growth (last year)+6.31%
P/E ratio16.1
Price/Sales4.86
Price/Book4.07

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.40-0.59%
BIIBBiogen-1.12-0.41%
ILMNIllumina Inc-1.48-0.86%
BIVVBioverativ Inc+1.22+2.40%
Data as of 03/28/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)$3.00
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts


Search for Jobs